The ultrasonic mating signal of the male lesser wax moth

Abstract. Male lesser wax moths, Achroia grisella (Fabricius) (Lepidoptera: Pyralidae: Galleriinae), produce both a pheromone and an ultrasonic acoustic signal that function in mate attraction. We describe the structure of the acoustic signal, in particular the interpulse intervals and the spectral properties of the pulses. The song consists of a train of ultrasonic pulses. The interpulse interval is usually bimodally distributed, but can sometimes be unimodal. This reflects variation in the duration of the up and down wing strokes. The pulses are also usually paired which can produce multimodality of the interpulse intervals. These paired pulses probably reflect wingbeat asynchrony because they are not found in males in which the signalling capability of one wing's sound producing structure is abolished. The song's frequency spectrum has peaks at around 80 and 100 kHz. The first peak varies significantly with male size, with larger males producing a lower frequency peak. The second peak is associated with male age, with 1‐day‐old males producing songs with a lower frequency second peak. Thus the ultrasonic song of lesser wax moths is more complex in structure than previously reported and could provide potentially important cues to females. However, the ability of females to discriminate such detail is not known.</p

Equitable expanded carrier screening needs indigenous clinical and population genomic data

Expanded carrier screening (ECS) for recessive monogenic diseases requires prior knowledge of genomic variation, including DNA variants that cause disease. The composition of pathogenic variants differs greatly among human populations, but historically, research about monogenic diseases has focused mainly on people with European ancestry. By comparison, less is known about pathogenic DNA variants in people from other parts of the world. Consequently, inclusion of currently underrepresented Indigenous and other minority population groups in genomic research is essential to enable equitable outcomes in ECS and other areas of genomic medicine. Here, we discuss this issue in relation to the implementation of ECS in Australia, which is currently being evaluated as part of the national Government's Genomics Health Futures Mission. We argue that significant effort is required to build an evidence base and genomic reference data so that ECS can bring significant clinical benefit for many Aboriginal and/or Torres Strait Islander Australians. These efforts are essential steps to achieving the Australian Government's objectives and its commitment "to leveraging the benefits of genomics in the health system for all Australians." They require culturally safe, community-led research and community involvement embedded within national health and medical genomics programs to ensure that new knowledge is integrated into medicine and health services in ways that address the specific and articulated cultural and health needs of Indigenous people. Until this occurs, people who do not have European ancestry are at risk of being, in relative terms, further disadvantaged.Simon Easteal, Ruth M. Arkell, Renzo F. Balbo ... Yassine Souilmi ... Alexander Brown ... Bastien Llamas ... et al